Syra Health Corp. The company is headquartered in Carmel, Indiana.
| Revenue (TTM) | $7.23M |
| Gross Profit (TTM) | $2.49M |
| EBITDA | -880,096 |
| Operating Margin | 0.00% |
| Return on Equity | -36.00% |
| Return on Assets | -17.50% |
| Revenue/Share (TTM) | $0.61 |
| Book Value | $0.12 |
| Price-to-Book | 2.53 |
| Price-to-Sales (TTM) | 0.80 |
| EV/Revenue | 0.408 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -13.60% |
| Shares Outstanding | $11.34M |
| Float | $6.81M |
| % Insiders | 39.91% |
| % Institutions | 0.00% |
Volatility is currently expanding
Revenue climbed 52% year-over-year to $2.6 million in Q3 2026, the highest quarterly revenue in the Company's history. Earnings per share (EPS) swung to $0.02 in Q3 2026, compared with a loss of $(0.02) in Q3 2025.
CARMEL, Ind., Oct. 27, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that it will report financial results for the three months ended September 30, 2026, on Tuesday, November 3, 2026.
CARMEL, Ind., Sept. 29, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that it has been awarded a contract by the Mississippi State Department of Health (MSDH) to provide epidemiology, evaluation, and biostatistics services.
CARMEL, Ind., Sept. 3, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that, in partnership with HealthSync, it has been accepted into the CMS (Centers for Medicare & Medicaid) ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model.
CARMEL, Ind., Sept. 1, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today the expansion of its partnership with Wake County Public Health, located in North Carolina.
Syra Health sustained profitability in Q2 2026, following the Company's first profitable quarter in Q1 2026, delivering net income of $250,242 compared with a net loss of $(63,596) in the prior-year period. Q2 2026 revenue grew 23% year-over-year to $2.4 million.
CARMEL, Ind., Aug. 4, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that it will report financial results for the three months ended June 30, 2026, on Tuesday, August 11, 2026.
CARMEL, Ind., July 7, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today the appointment of Dr. Cori McMahon, PsyD, NCCE, as Chief Medical Officer.
Syra Health delivered its first-ever profitable quarter in Q1 2026, with net income of approximately $241,000, representing a substantial 151% increase over the year-ago period Q1 2026 EPS grew to $0.02 per share versus ($0.04) in Q1 2025 Gross Margin rose to 42.7%, up 11 percentage points year-over-year Total revenue increased to $2.3 million, up 22% when compared to the prior year period CARMEL, Ind., May 7, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today its financial results for the first quarter ended March 31, 2026.
CARMEL, Ind., April 30, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that it will report financial results for its first quarter ended on March 31, 2026, on Thursday, May 7, 2026.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SYRA and any ticker you trade — then tracks every position and per-strategy win rate.
